Spectranetics gets speedy PMA review

17 Jun 2002

The FDA has agreed to expedite its premarket-approval application (PMA) review of an excimer-laser sheath developed by Spectranetics (Colorado Springs, CO). According to the company, this means the laser sheath, used to remove pacemaker and implantable cardioverter defibrillator leads, could move from investigational-device status to full market release at a faster pace than originally projected.
Courtesy of Laser Focus World